The session took place on 13 December 2022 at 2pm.
Shareholders were invited to ask questions during the live session, and a recording of the event is now available.
ValiRx CEO, Dr Suzy Dilly, said: “I look forward to meeting shareholders in our webinar, which is an open forum in which we will endeavour to answer all questions and concerns.
“We welcome questions from our shareholders, as well as individuals considering becoming shareholders. ValiRx is committed to communicating transparently and addressing all queries in a clear, concise, and factual manner.”
View the presentation here.
View the PDF presentation here.